In this new monthly series we’ll be speaking to the provider of our Alcohol and Other Drug (AOD) commissioned services in South Western Sydney. These services funded by SWSPHN are free for individuals accessing them. For more information or assistance, please contact Nick McGhie – nick.mcghie@swsphn.com.au
In this column we’ll be looking at the General Practice Drug and Alcohol Advice and Support Service.
Name of service provider
General Practice Drug and Alcohol Advice and Support Service
What service/s do you provide?
- Clinical advice and support
- Case conferences
- Support in commencement and ongoing care of patients requiring buprenorphine treatment of opioid dependence
- Access to specialist drug health services including withdrawal services
Please provide a brief description of the service/s you provide
Immediate, direct access for GPs to the telephone helpline – linking you with local consultant drug health clinicians (including the medical team.) Provides advice, assessments, and case conferences with the patient and primary carer.
Supports general practice in managing dependence and withdrawal from all substances.
Provides advice on referral pathways and other local AOD services that provide psychosocial care.
The telephone helpline can be contacted on 0455 079 436.
In which LGAs are your services available?
All LGAs within the South Western Sydney Local Health District / PHN area.
Who is eligible to access your service?
All GPs practising within SWSLHD/PHN boundary.
Does the service provide support for people who don’t speak English as a first language?
Yes, it can be arranged for translators to be present.
Who can GPs contact for more information about your service?
Dr Jenny James, General Practitioner VMO Drug Health Services SWS Jennifer.James3@health.nsw.gov.au or call 0467 717 832 (Mondays and Tuesdays only).
How do GPs refer to your service?
GPs with any clinical query or patient history they would like to discuss can call the helpline Monday to Friday (excluding public holidays), 9.30am to 5pm, on 0455 079 436. They will have immediate access to a South Western Sydney drug health clinician.
Case study
Please share an experience where a GP has referred a patient to your service.
Why were they referred?
The patient was referred for help with assessment and discussion of management options for prescription opioid use. They were ingesting 100mg oxycodone SR daily, in three divided doses.
How did you interact with the referring GP?
The GP rang our helpline (0455 079 436) and spoke with our CNC about the clinical issues. Our CNC rang the patient and did a telephone assessment and gave the patient some management options. The patient had opioid dependence and was keen to commence treatment with buprenorphine. The patient was referred back to the GP after he was stabilised on a monthly depo injection of buprenorphine at Drug Health Services. Our team had a telephone case conference with the GP at the point of transition back to GP care so we could discuss ongoing clinical management with Buvidal. Our team also set up all the arrangements with the pharmacy that supplies the Buvidal to the GP. The GP can continue to call our helpline at any time in the future as needed.
What was the outcome for the patient/client?
The patient attended Drug Health Services as an outpatient for a short time and was stabilised on a dose of injectable depo buprenorphine – 128mg monthly. He continues to attend his GP for his monthly Buvidal injections and no longer ingests any opioids and continues to work full time and feels very happy with his treatment.
What was your experience like working with the GP?
Terrific. The GP was very interested in helping her patient obtain access to an excellent evidence-based treatment that broke the cycle of continually seeking opioids. She was also pleased to extend her skill set.
Did you receive any feedback from the GP or patient/client in regard to shared care?
The GP found the support very helpful and easy to access.
Please share what you think the benefits of GP referrals to your service and the referring GP are?
The benefits are extensive. They include improving transition of care between GPs and specialist drug health services, extending the skill sets of GPs in the area of AOD treatments, and opening up evidence-based treatment options for patients within the primary health care domain.

